Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure
Márcia Maria Carneiro Oliveira1, Elieusa E Silva Sampaio1, Jun Ramos Kawaoka2
1Escola de Enfermagem da Universidade Federal da Bahia, Salvador, BA - Brazil.
Insights
Heart failure increases the risk of silent cerebral infarction, particularly in patients with reduced left ventricular ejection fraction. Lower ejection fraction correlates with a higher prevalence of these brain injuries.
Area of Science:
- Cardiology
- Neurology
- Radiology
Background:
- Heart failure is linked to a higher risk of silent cerebral infarction.
- Data on left ventricular ejection fraction's role in silent cerebral infarction is limited.
- Understanding these associations is crucial for patient management.
Purpose of the Study:
- To investigate clinical and echocardiographic factors of silent cerebral infarction in heart failure patients.
- To analyze these factors across different left ventricular ejection fraction groups.
- To identify predictors of silent cerebral infarction in heart failure.
Main Methods:
- Prospective cohort study of 75 heart failure patients.
- Categorization into reduced (≤40%), mid-range (41-49%), and preserved (≥50%) ejection fraction groups.
- Cranial tomography and echocardiography (transthoracic and transesophageal) performed on all participants.
Main Results:
- Silent cerebral infarction found in 14.7% of patients, more common in the reduced ejection fraction group (29%).
- No silent cerebral infarction cases in the preserved ejection fraction group.
- Reduced and mid-range ejection fractions were associated with territorial and lacunar infarcts, respectively; diabetes mellitus was also a risk factor.
Conclusions:
- Reduced and mid-range left ventricular ejection fractions are associated with silent cerebral infarction in heart failure.
- Lower ejection fraction correlates with increased silent cerebral infarction prevalence.
- Further research into preventing silent cerebral infarction in heart failure is warranted.
Abstract:
Heart failure predisposes to an increased risk of silent cerebral infarction, and data related to left ventricular ejection fraction are still limited. Our objective was to describe the clinical and echocardiographic characteristics and factors associated with silent cerebral infarction in patients with heart failure, according to the left ventricular ejection fraction groups. A prospective cohort was performed at a referral hospital in Cardiology between December 2015 and July 2017. The left ventricular ejection fraction groups were: reduced (≤ 40%), mid-range (41-49%) and preserved (≥ 50%). All patients underwent cranial tomography, transthoracic and transesophageal echocardiography. Seventy-five patients were studied. Silent cerebral infarction was observed in 14.7% of the study population (45.5% lacunar and 54.5% territorial) and was more frequent in patients in the reduced left ventricular ejection fraction group (29%) compared with the mid-range one (15.4%, p = 0.005). There were no cases of silent cerebral infarction in the group of preserved left ventricular ejection fraction. In the univariate analysis, an association was identified between silent cerebral infarction and reduced (OR = 8.59; 95%CI: 1.71 - 43.27; p = 0.009) and preserved (OR = 0.05; 95%CI: 0.003-0.817, p = 0.003) left ventricular ejection fraction and diabetes mellitus (OR = 4.28, 95%CI: 1.14-16.15, p = 0.031). In patients with heart failure and without a clinical diagnosis of stroke, reduced and mid-range left ventricular ejection fractions contributed to the occurrence of territorial and lacunar silent cerebral infarction, respectively. The lower the left ventricular ejection fraction, the higher the prevalence of silent cerebral infarction.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

